MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Penicillamine"

  • 2025 International Congress

    Wilson’s Disease with Hereditary Hemorrhagic Telangiectasia and Pituitary Microadenoma: A Case Report

    D. Dai, L. Li, X. Xu (Urumqi, China)

    Objective: To report a case of a young female patient with Wilson's disease, hereditary hemorrhagic telangiectasia (HHT), and pituitary microadenoma, and to enhance the understanding…
  • 2024 International Congress

    Real-life experience of switching from D-penicillamine to trientine tetrahydrochloride – a nationwide registry study

    A. Poujois, MA. Obadia, N. Oussedik-Djebrani, E. Couchonnal-Bedoya, D. Debray (PARIS, France)

    Objective: Our aim was to assess the efficacy and safety of trientine tetrahydrochloride (TETA4HCL) in a cohort of neurological Wilson's disease (WD) patients transitioned from…
  • 2024 International Congress

    Wilson’s Disease About A Complex Case

    A. Ouedraogo, V. Ouedraogo, A. Savadogo (Bobo-Dioulasso, Burkina Faso)

    Objective: We report the case of a patient who experienced diagnostic wavering. Background: Wilson disease is a rare disease. Cases in Africa is even rarer.…
  • 2023 International Congress

    D-penicillamine induced myasthenia gravis – the possible complication of Wilson’s disease treatment.

    A. Antos, T. Litwin, J. Bembenek, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)

    Objective: D-penicillamine (DPA) belongs to the most frequently used drugs in Wilson’s disease (WD) treatment. Despite the effectiveness in WD treatment, DPA could be involved in many…
  • MDS Virtual Congress 2021

    D-penicillamine induced lupus erythematosus – the complication of Wilson’s disease treatment – a case report.

    A. Antos, T. Litwin, A. Przybyłkowski, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)

    Objective: Wilson’s disease (WD) is an inherited disorder of copper metabolism with copper accumulation in different organs and clinical symptoms related to the affected organs…
  • MDS Virtual Congress 2020

    Sensory Trick in Oromandibular and Tongue Dystonia in Patient with Wilson’s Disease

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the case report is to demonstrate an unusual clinical feature of secondary dystonia. Background: A sensory trick (ST) is a voluntarily…
  • 2019 International Congress

    Acquired (non-Wilsonian) hepatocerebral degeneration: case report

    E. Gracheva, I. Miliukhina, A. Sokolov, YU. Seliverstov (St.petersburg, Russian Federation)

    Objective: To present a case of the patient with acquired (non-Wilsonian) hepatocerebral degeneration (AHD). Background: AHD is a clinical syndrome which includes movement and cognitive…
  • 2018 International Congress

    Neurologic Wilson’s Disease: Case Series on a Diagnostic and Therapeutic Emergency

    R. Porlas, L. De Castillo, C. Dioquino (Manila, Philippines)

    Objective: To present two cases of Neurologic Wilson's Disease with two different clinical picture. To review the the important diagnostics and tests in clinching the…
  • 2018 International Congress

    Explosive flurry of seizures and new-onset cortical-subcortical lesions in a patient with Wilson disease

    A. Aggarwal, M. Munshi, P. Gadgil, D. Sanghvi, M. Bhatt (Mumbai, India)

    Objective: We report a patient with stable neurological Wilson disease (WD) who developed repeated seizures and new-onset cortical-subcortical lesions, and discuss the possible causes for…
  • 2017 International Congress

    Neurological worsening in patients undergoing treatment for Wilson disease: Frequency, causes and outcomes.

    A. Aggarwal, M. Bhatt (Mumbai, India)

    Objective: To study the pattern of neurological worsening (NW) in patients undergoing treatment for Wilson disease (WD). Background: WD is an inherited disorder of copper…
  • 1
  • 2
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley